Angela Cramer
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
- Oncology 8
- HER2/EGFR in Cancer Research 5
- Cancer Treatment and Pharmacology 2
-
- Advanced Breast Cancer Therapies 2
- Prostate Cancer Treatment and Research 1
- Co-authors
- Nigel Bundred (8 shared papers)W.F. Knox (4 shared papers)G.P. Boland (2 shared papers)Nicola Barnes (2 shared papers)Fiona Knox (4 shared papers)R.J. Johnson (2 shared papers)Julie Morris (2 shared papers)Kathryn Williams (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Cancer Research (2 papers)Annals of Oncology (1 paper)Journal of Dental Research (1 paper)npj Breast Cancer (1 paper)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Angela Cramer
17 papers receiving 524 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 157
- Oncology 248
- Genetics 124
- Immunology and Allergy 24
- Pathology and Forensic Medicine 70
Countries citing papers authored by Angela Cramer
This map shows the geographic impact of Angela Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Cramer more than expected).
Fields of papers citing papers by Angela Cramer
This network shows the impact of papers produced by Angela Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Cramer. The network helps show where Angela Cramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Angela Cramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 120 | |
| 2 | 2015 | 92 | |
| 3 | 2009 | 74 | |
| 4 | 2006 | 60 | |
| 5 | 2011 | 48 | |
| 6 | 2010 | 35 | |
| 7 | 2021 | 26 | |
| 8 | 2003 | 23 | |
| 9 | 2012 | 20 | |
| 10 | 2018 | 18 | |
| 11 | Effects of perioperative lapatinib and trastuzumab, alone and in combination, in early HER2+breast cancer - the UK EPHOS-B trial (CRUK/08/002) | 2016 | 4 |
| 12 | Ulcerated breast cancer. Patients and outcome. | 1983 | 4 |
| 13 | 2006 | 4 | |
| 14 | 2016 | 2 | |
| 15 | 2010 | 2 | |
| 16 | 2009 | 1 | |
| 17 | 2010 | 1 |
About Angela Cramer
Angela Cramer is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Molecular Biology and Epidemiology, having authored 17 papers that have together received 534 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Estrogen and related hormone effects (2 papers), Cancer Treatment and Pharmacology (2 papers), Advanced Breast Cancer Therapies (2 papers), Cell Adhesion Molecules Research (2 papers), Breast Cancer Treatment Studies (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Prostate Cancer Treatment and Research (1 paper). The work is most often cited by research in Cancer Research (157 citations), Oncology (248 citations), Genetics (124 citations), Immunology and Allergy (24 citations) and Pathology and Forensic Medicine (70 citations). Angela Cramer has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Nigel Bundred, W.F. Knox, G.P. Boland, Nicola Barnes, Fiona Knox, R.J. Johnson, Julie Morris, Kathryn Williams, Miles Howe and Fiona Lalloo. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Annals of Oncology, Journal of Dental Research and npj Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.